General Information
Overview
CEC is pleased to host the 11th Annual Diabetes, Obesity, & Metabolic Disease Conference in New Orleans, Louisiana, at the Sheraton New Orleans Hotel on May 1-3, 2026.
It is estimated that more than 1/3 of Americans suffer from a cardiometabolic disorder, a cluster of health conditions associated with cardiovascular disease and Type 2 diabetes. The associated morbidity and mortality deserve increased attention as clinicians address risk factors predisposing individuals to these disorders. This CME program will help healthcare providers identify these conditions and their related complications, and will address how to appropriately intervene with evidence-based treatments and risk-factor controls.
Participate in enriching half-day sessions exploring the latest developments in diabetes, obesity, and metabolic disease. With your free afternoons to enjoy the many incredible attractions of New Orleans, this conference is designed to enhance clinical skills while offering a rejuvenating Big Easy escape.
Program Objectives
As a result of this conference, participants will be able to:
- Diagnose and identify cardiometabolic risk factors, including diabetes, dyslipidemia, hypertension, and obesity.
- Integrate evidence-based strategies and recent guidelines for the screening, prevention, and treatment of cardiometabolic risk factors and their comorbidities in clinical practice.
- Incorporate appropriate interventions, including lifestyle modifications, nutrition counseling, and drug and surgical therapies, based on a specific patient’s risk profile.
Target Audience
This conference is designed for Physicians, Nurse Practitioners, Physician Assistants, and other related healthcare professionals involved in the treatment of patients at risk for cardiometabolic disorders.
Educational Sessions
| Day 1: Diabetes, Cardio-Renal Disease Management with Cases, and MASLD/MASH with Case Studies | ||
| 7:50 am – 8:00 am | Welcome | A. Mullins, CHCP & J. Basile, MD |
| 8:00 am – 8:45 am | A Holistic Person-Centered Approach to Type 2 Diabetes Care | V. Aroda, MD |
| 8:45 am – 9:30 am | The Cardiovascular-Kidney-Metabolic Health Construct: Moving Away from Silos | J. Rangaswami, MD |
| 9:30 am BREAK | ||
| 9:45 am – 10:30 am | Exploration of Gut Hormone Drugs: Current Status and Pipeline | V. Aroda, MD |
| 10:30 am – 11:15 am | Combination Therapies in Kidney Disease: Saving Lives, Hearts, and Kidneys | J. Rangaswami, MD |
| 11:15 am – 11:30 am | Questions for Faculty | J. Rangaswami, MD & V. Aroda, MD |
| 11:30 am – 12:30 pm | Cases in Diabetes, Renal, and Cardio-Kidney Metabolic Disease | J. Rangaswami, MD & V. Aroda, MD |
| 12:30 pm LUNCH BREAK (Working Lunch) | ||
| 12:30 pm – 1:45 pm | Early identification and Management of Individuals At-Risk for MASH | F. Bril, MD |
| 1:45 pm – 2:45 pm | Clinical Decision Making in MASLD/MASH: A Case-Based Approach | F. Bril, MD |
SATURDAY, May 2, 2026
| Day 2: Comprehensive Obesity Management | ||
| 7:40 am – 7:45 am | Welcome | A. Mullins, CHCP |
| 7:45 am – 8:00 am | Day One Review | J. Basile, MD |
| 8:00 am – 8:45 am | New Ways of Thinking About Obesity | D. Ryan, MD |
| 8:45 am – 9:30 am | Obesity: A Practical Guide to Diagnosis, Staging, and Front-Line Therapies | C. Still, MD |
| 9:30 am BREAK | ||
| 9:45 am – 10:30 am | Metabolic and Bariatric Surgery: Is it Still an Option? | C. Still, MD |
| 10:30 am – 11:15 am | Incretins and Nutrient Stimulating Hormone Targeted Meds – Weight Loss and Beyond | D. Ryan, MD |
| 11:15 am – 11:30 am | Questions for the Faculty | D. Ryan, MD & C. Still, MD |
| 11:30 am – 12:30 pm | Cases in Obesity Management | D. Ryan, MD & C. Still, MD |
SUNDAY, May 3, 2026
| Day 3: Hypertension and Dyslipidemia Management with Case Studies | ||
| 7:40 am – 7:45 am | Welcome | A. Mullins, CHCP |
| 7:45 am – 8:00 am | Day Two Review | J. Basile, MD |
| 8:00 am – 9:00 am | Clinical Pearls in Outpatient HTN: What’s New in the 2025 HTN Guideline | J. Basile, MD |
| 9:00 am – 10:00 am | The 2026 Updated ACC/AHA Dyslipidemia Guideline: What’s New, What’s Not | L. Sperling, MD |
| 10:00 am BREAK | ||
| 10:15 am – 11:00 am | Focus on Lipid-Related Risk as a Component of Comprehensive Cardio-Kidney-Metabolic Health | L. Sperling, MD |
| 11:00 am – 11:15 am | Questions for the Faculty | J. Basile, MD & L. Sperling, MD |
| 11:15 am – 12:15 pm | Cases on HTN and Lipids | J. Basile, MD & L. Sperling, MD |

AAFP Geriatric Medicine Self-Study Package – 11th Edition 2020
The PassMachine How Not to Fail Your Psychiatry Board Exam 2020 

